Other papers that might interest you

To feature here :  Get in touch 



14/11/2014 - Agfa HealthCare

Reducing dose is on everyone’s agenda! Today, only a small proportion of patients receive the lowest imaging radiation dose technically possible. But more and more, across the entire medical community, we are becoming aware of the need to join forces to further improve radiation safety. This is e...



19/11/2013 - MEDIAN Technologies

mRECIST is now recommended by the European Association for the Study of the Liver(EASL) for clinical studies on advanced hepatocellular carcinoma (HCC) as it better fits disease evolution assessment than standard RECIST does.However, mRECIST for HCCis more complex than RECIST. Its management in c...